Kaylynn Aiona

Transcriptional Landscape of the Prenatal Human Brain

Allan R. Jones, John W. Phillips, M. Gerstein, 2014, Nature.

Comprehensive transcriptional map of primate brain development

Allan R. Jones, Trygve E Bakken, John W. Phillips, 2016, Nature.

Clinical Characteristics of Active Tuberculosis Diagnosed after Starting Treatment for Latent Tuberculosis Infection.

R. Reves, Kaylynn Aiona, R. Belknap, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comprehensive transcriptional map of primate brain development 1 2

Allan R. Jones, Trygve E Bakken, John W. Phillips, 2016 .

Higher Completion Rates with Self-administered Once-weekly Isoniazid-Rifapentine versus Daily Rifampin in Adults with Latent Tuberculosis.

Kaylynn Aiona, R. Belknap, K. Erlandson, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The disparate impact of age-based COVID-19 vaccine prioritization by race/ethnicity in Denver, Colorado

Kaylynn Aiona, L. Podewils, Emily Bacon, 2022, Health Policy OPEN.

Better Completion of Pediatric Latent Tuberculosis Treatment Using 4 Months of Rifampin in a US-based Tuberculosis Clinic

R. Reves, Kaylynn Aiona, R. Belknap, 2017, The Pediatric infectious disease journal.

Transnational Record Linkage for Tuberculosis Surveillance and Program Evaluation

R. Reves, Kaylynn Aiona, N. Walter, 2015, Public health reports.

Interferon-Gamma Release Assay Testing in Children Younger Than 2 Years in a US-Based Health System

Kaylynn Aiona, R. Belknap, M. Haas, 2020, The Pediatric infectious disease journal.

Using Electronic Health Record Data to Measure the Latent Tuberculosis Infection Care Cascade in Safety-Net Primary Care Clinics

Kaylynn Aiona, R. Belknap, Jee Oakley, 2023, AJPM focus.

Factors Associated With the Discontinuation of Two Short-Course Tuberculosis Preventive Therapies in Programmatic Settings in the United States

R. Garfein, Kaylynn Aiona, T. Venkatappa, 2024, Open forum infectious diseases.